Skip to main content
Erschienen in: BMC Urology 1/2023

Open Access 01.12.2023 | Case Report

Simultaneous adrenal and retroperitoneal myelolipoma resected by laparoscopic surgery: a challenging case

verfasst von: Hooman Kamran, Abdolreza Haghpanah, Mohammad Hossein Dabbaghmanesh, Lorenzo Defidio, Maryam Bazrafkan, Anahita Dehghani, Mehdi Shirazi, Nima Naderi, Amirreza Dehghanian

Erschienen in: BMC Urology | Ausgabe 1/2023

Abstract

Background

Myelolipoma is a benign neoplasm of the adrenal cortex, composed of fat and hematopoietic cells. Although myelolipoma is benign, differentiation from adrenocortical cancer may be difficult. The presence of adrenal and extra-adrenal myelolipomas simultaneously is sporadic, making it a challenging case, especially when the preoperative diagnosis is ambiguous.

Case presentation

A 65-year-old man was referred to our clinic due to a mass in the adrenal fossa. In the abdominopelvic computed tomography (CT), a well-circumscribed fat-containing 78 × 61 × 65 mm bi-lobulated mass was reported in the left adrenal fossa. The first differential diagnosis was myelolipoma. The patient was then referred to our clinic for a mass excision. He was asymptomatic and was scheduled to undergo laparoscopic-assisted adrenalectomy. After adrenalectomy and mass dissection, surprisingly, another mass was detected in the retroperitoneal area. The second mass was also dissected. The final diagnosis was myelolipoma for both masses. The patient has been symptom-free for nine months after the operation.

Conclusion

Simultaneous adrenal and extra-adrenal myelolipoma should be considered as one of the differential diagnoses. However, because this situation is extremely rare, the probability of malignancy should be highly regarded, and we suggest an obsessive approach when approaching this condition. It is essential to manage these cases on a case-by-case basis and tailor the management concerning intraoperative biopsy, the intraoperative appearance of tumors, and the location of extra-adrenal masses.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Myelolipoma is a benign neoplasm of the adrenal cortex composed of fat and hematopoietic cells [1, 2]. Most myelolipomas are found incidentally due to their asymptomatic presentation [3]. Besides, because of the increase in using abdominal imaging, the incidence rate of these neoplasms is rising, accounting for 6–16% of adrenal incidentalomas [4]. Based on the study by Calissendorff et al. [5], reviewing the epidemiology of adrenal myelolipomas, these masses comprised 3.3–3.6% and 1.8–6.5% of all adrenal tumors in a population and in endocrine clinics, respectively. Also, the prevalence of myelolipoma in the normal population was reported to be 0.32% (at 40 years of age) [6]. In addition, they usually present unilaterally (95%) at the time of diagnosis [5].
Myelolipomatous lesions have three patterns on imaging; isolated adrenal myelolipoma, myelolipoma with hemorrhage, and myelolipomatous foci with other adrenal pathologic conditions [3, 7]. Although myelolipoma is benign, differentiation from adrenocortical cancer may be challenging due to variable fat and hematopoietic portions [1]. Extra-adrenal myelolipoma has been infrequently presented in the literature [8], and retroperitoneal space is the most common location for extra-adrenal myelolipomas [9]. However, myelolipomas in other regions, including the mediastinum and other abdominal organs, have also been reported [1012]. Based on our search in PubMed, about 130 cases of extra-adrenal myelolipoma have been reported in the English literature. The presence of adrenal and extra-adrenal myelolipomas simultaneously is sporadic, making it a challenging case, especially when the preoperative diagnosis is ambiguous [13]. Here, we aim to present a patient with simultaneous adrenal and retroperitoneal myelolipomas excised by laparoscopic surgery.

Case presentation

A 65-year-old man with a past medical history of papillary thyroid carcinoma and eye cataract was referred to our clinic due to a mass in the adrenal fossa. On admission, the patient had an approximate body mass index (BMI) of 30 kg/m2, the vital signs were stable, and except for the absence of the thyroid gland, the physical exam did not show any abnormalities.

History

The patient underwent radical thyroidectomy due to papillary thyroid carcinoma and took levothyroxine. He had been under follow-up with an endocrinologist regarding this issue. On one of his visits to the endocrinologist, calcium, phosphorous, and hormonal assessment alongside neck, chest and mediastinum, and abdominopelvic computed tomography (CT) scan was ordered to be performed. In the blood test, calcium, phosphorous, T4, antithyroglobulin antibody, and thyroglobulin were within the normal range, but thyroid-stimulating hormone (TSH) was 0.05 (reference range: 0.27–5.95). Also, 24-hour urine levels of cortisol, vanillylmandelic acid (VMA), metanephrine, and normetanephrine, measured to exclude the presence of a possible pheochromocytoma, were within the normal range. However, in the abdominopelvic CT, a well-circumscribed fat-containing 78 × 61 × 65 mm bi-lobulated mass was detected in the left adrenal fossa, resulting in inferior and posterior displacement of the left kidney. The first differential diagnosis was myelolipoma. Besides, no enhancing nodule or solid part was seen (Fig. 1). The patient was then referred to our clinic for a mass excision. He was asymptomatic and was scheduled to undergo laparoscopic-assisted adrenalectomy.

Hospital course

The patient was admitted to the hospital two days before the operation. Preoperative consultations, including endocrinology, cardiology, and anesthesiology consults, were done, which showed no contraindications for surgery.
The operation was performed under general anesthesia. The patient was placed in a lateral position. Four ports were inserted, including one for the laparoscope and three for the working ports. After transperitoneal exploration, adrenalectomy was done, and the mass was dissected. Then, when exploring the adrenal fossa, surprisingly, another mass was detected in the retroperitoneal area. The second mass was also dissected, and both masses were excised via a Pfannenstiel incision (Fig. 2). A Penrose drain was inserted, and the incision and trocar sites were closed layer by layer. The operative duration was approximately four hours. The masses were also sent for pathological evaluation.
The postoperative hospital course was uneventful, and the patient was discharged two days after surgery in good condition.

Pathological evaluation

In the gross examination, both masses were reported as ill-defined masses with creamy yellow color. The size of the adrenal and retroperitoneal masses was 3.5 × 2 × 1 cm and 4 × 3 × 3 cm, respectively. The final diagnosis was myelolipoma for both masses (Fig. 3).

Follow-up

Currently, the patient is under the follow-up of his endocrinologist. Besides, he has no complaints and has been symptom-free since the operation (a nine-month follow-up).

Discussion

In the literature, simultaneous adrenal and extra-adrenal myelolipomas are reported exceptionally rarely. The importance of such cases is their challenging management due to the rarity of these situations and the ambiguity of pathologies in the pre-surgical diagnosis. A case report by Zieker et al. [10] presented a 75-year-old man with adrenal and infrarenal myelolipomas. The preoperative diagnosis was a benign adrenal mass alongside a retroperitoneal liposarcoma in their report. So, the authors planned to perform an adrenalectomy with an intraoperative biopsy of the infrarenal mass. Their case shows that the rarity of this presentation and an insecure preoperative diagnosis may challenge the physicians when confronting these patients, especially when the probability of misdiagnosis with malignant tumors is considered. Here, we present a challenging case with simultaneous adrenal and retroperitoneal myelolipomas. In our case, although the preoperative imaging favored myelolipoma, the tumors were reported to be a single bi-lobulated mass. This was while two separated tumors were found during the operation.
The clinical diagnosis of myelolipomas is impractical because most myelolipomas are asymptomatic and are found incidentally. Based on the study by Hamidi et al. [4], which evaluated 321 myelolipomas in 305 patients, 86% of tumors were found incidentally, and only 5% were discovered due to mass effect symptoms. On the other hand, in a review article reviewing 420 cases of adrenal myelolipoma from 1957 to 2017, the most common leading complaints were abdominal discomfort/pain (22.5%) followed by hypochondrial pain (13.9%) and flank pain (13.9%) [1]. Adrenal myelolipomas can rarely present with dyspnea, back pain, fever, weight loss, and virilization [14]. Therefore, myelolipomas-related symptoms, which can result from mass effect symptoms or even acute abdomen because of tumor compression or hemorrhage, are unspecific for diagnosing these tumors [15]. So, further diagnostic approaches are required.
Imaging tools and biopsy are helpful tools for the diagnosis of myelolipomas. In ultrasonography, as the primary imaging tool, myelolipomas have variable appearances based on their composition. Although ultrasound is limited for diagnosis, especially when the mass is small, myelolipomas typically appear as a heterogeneous hyperechoic mass [1, 16]. However, based on the predominant part, it may be hyperechoic (mostly fat) or hypoechoic (mostly myeloid cells) [17]. Also, calcification may be seen [1, 17]. On CT, myelolipomas typically present as well-circumscribed, heterogenous, and hypodense masses, and the presence of fat favor adrenal myelolipoma [1, 16]. However, extra-adrenal myelolipomas have less fat composition and cannot be differentiated clearly from other fat-containing retroperitoneal masses [7, 16]. Also, in magnetic resonance imaging (MRI), hyperintensity of fat on T1 and T2 weighted sequences favor myelolipoma [16]. When imaging cannot exclude malignancy, a fine needle biopsy may be helpful [15].
The differential diagnoses of fat-containing retroperitoneal masses include tumors originating from adrenal (adenoma, myelolipoma), kidney (angiomyolipoma), and pancreas (lipoma, focal pancreatic steatosis), and primary retroperitoneal masses (lipoma, liposarcoma) [18]. Of note, although liposarcoma has been reported to be extremely rare in the adrenal [19, 20], it is one of the most common retroperitoneal fat-containing tumors [16]; the incidence of retroperitoneal liposarcoma has reported to be 2.5 per million population, comprising 20% of all retroperitoneal sarcomas [21]. So, myelolipomas, especially retroperitoneal, may be misdiagnosed as other tumors, including liposarcoma.
Concerning the management of myelolipomas, surgery is indicated in the presence of tumor-associated symptoms with a large-sized mass, suspected malignancy, and tumor growth or hemorrhage [4]. However, conservative management seems sufficient when the diagnosis of myelolipoma is unambiguous and the issues above are absent. As a benign tumor, laparoscopic surgery is safe, and follow-up is optional because the malignant transformation has not been reported [1, 15].
The management of simultaneous adrenal and extra-adrenal myelolipoma is more challenging. One reason is the extreme rarity of these cases. So, the management must be considered on a case-by-case basis. Our report and the report by Zieker et al. [13] show that simultaneous presentation of myelolipoma should be considered when it is suspicious in the pre-treatment imaging. However, we suggest a more obsessive approach when confronting these patients. Because this situation is extremely rare, the probability of malignancy, especially retroperitoneal liposarcoma, should be highly considered. We designed a simplified algorithm when preoperative single or multiple myelolipomas are considered (Fig. 4). According to the algorithm, open surgery with intraoperative biopsy is suggested when malignancy is suspected in multiple myelolipomas. On the other hand, laparoscopic surgery is indicated when malignancy is not suspected; however, due to the reasons above, a more obsessive approach is recommended by performing an intraoperative biopsy. Although this algorithm may help manage such cases, it is simplified, and managing these challenging situations must be made case by case. This algorithm is just a simplified approach showing our opinion on the subject and is not a validated algorithm. The management should be tailored regarding intraoperative biopsy, the intraoperative appearance of tumors, and the location of extra-adrenal masses.
In our case, because the mass was preoperatively considered to be a single bi-lobulated myelolipoma, we scheduled a laparoscopic surgery due to the large size of the mass and the bi-lobulated appearance of the mass, considering the probability of separate masses. And surprisingly, two masses were seen during the operation. After adrenalectomy, the adrenal mass was observed to be smaller than the reported size in the preoperative CT scan. So, the retroperitoneal space was explored, and a retroperitoneal mass was found. Based on the lack of suspected malignancy and the appearance of the retroperitoneal mass, which was round, well-differentiated, and utterly similar to the excised adrenal mass, no intraoperative frozen section was sent. In the case by Zieker et al. [13], the management was done similar to our algorithm, and open surgery with intraoperative biopsy was performed due to the suspected malignancy for the retroperitoneal mass.

Conclusion

As the presence of simultaneous adrenal and extra-adrenal myelolipoma is extremely rare, its management is more challenging than a single mass. It should be considered as one of the differential diagnoses. However, because this situation is extremely rare, the probability of malignancy, especially retroperitoneal liposarcoma, should be highly considered, and we suggest an obsessive approach when approaching this condition. It is important to manage these cases on a case-by-case basis and tailor the management concerning intraoperative biopsy, the intraoperative appearance of tumors, and the location of extra-adrenal masses. Of note, as this study is only a case report, maybe, the proposed algorithm cannot be generalized to all patients presenting with simultaneous adrenal and extra-adrenal myelolipoma in the future. Therefore, future reports may help the literature on the approach to simultaneous adrenal and extra-adrenal tumors, including myelolipomas.

Acknowledgements

None.

Declarations

Competing interests

The authors declare no competing interests.
Written informed consent was obtained from the patient.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59(1):7–15.CrossRefPubMed Decmann Á, Perge P, Tóth M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59(1):7–15.CrossRefPubMed
2.
Zurück zum Zitat Nabi J, Rafiq D, Authoy FN, Sofi GN. Incidental detection of adrenal myelolipoma: a Case Report and Review of Literature. Case Rep Urol. 2013;2013:789481.PubMedPubMedCentral Nabi J, Rafiq D, Authoy FN, Sofi GN. Incidental detection of adrenal myelolipoma: a Case Report and Review of Literature. Case Rep Urol. 2013;2013:789481.PubMedPubMedCentral
3.
Zurück zum Zitat Gershuni VM, Bittner JG, Moley JF, Brunt LM. Adrenal myelolipoma: operative indications and outcomes. J Laparoendosc Adv Surg Tech. 2013;24(1):8–12.CrossRef Gershuni VM, Bittner JG, Moley JF, Brunt LM. Adrenal myelolipoma: operative indications and outcomes. J Laparoendosc Adv Surg Tech. 2013;24(1):8–12.CrossRef
4.
Zurück zum Zitat Hamidi O, Raman R, Lazik N, Iniguez-Ariza N, McKenzie TJ, Lyden ML, et al. Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study. Clin Endocrinol. 2020;93(1):11–8.CrossRef Hamidi O, Raman R, Lazik N, Iniguez-Ariza N, McKenzie TJ, Lyden ML, et al. Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study. Clin Endocrinol. 2020;93(1):11–8.CrossRef
5.
Zurück zum Zitat Calissendorff J, Juhlin CC, Sundin A, Bancos I, Falhammar H. Adrenal myelolipomas. The lancet Diabetes & endocrinology. 2021;9(11):767–75.CrossRef Calissendorff J, Juhlin CC, Sundin A, Bancos I, Falhammar H. Adrenal myelolipomas. The lancet Diabetes & endocrinology. 2021;9(11):767–75.CrossRef
6.
Zurück zum Zitat Nermoen I, Falhammar H. Prevalence and characteristics of adrenal tumors and myelolipomas in congenital adrenal hyperplasia: a systematic review and meta-analysis. Endocr Pract. 2020;26(11):1351–65.CrossRefPubMed Nermoen I, Falhammar H. Prevalence and characteristics of adrenal tumors and myelolipomas in congenital adrenal hyperplasia: a systematic review and meta-analysis. Endocr Pract. 2020;26(11):1351–65.CrossRefPubMed
7.
Zurück zum Zitat Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology. 1998;208(1):87–95.CrossRefPubMed Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology. 1998;208(1):87–95.CrossRefPubMed
8.
Zurück zum Zitat Beiko D, Roldan H, Sengupta SK, George RL. Laparoscopic excision of a large extra-adrenal perirenal myelolipoma. Can Urol Assoc J. 2010;4(2):E39–E41.CrossRefPubMedPubMedCentral Beiko D, Roldan H, Sengupta SK, George RL. Laparoscopic excision of a large extra-adrenal perirenal myelolipoma. Can Urol Assoc J. 2010;4(2):E39–E41.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cho J, Kinsey D, Kimchi ET, O’Carroll KS, Nguyen V, Alsabbagh M, et al. Retroperitoneal extra-adrenal myelolipoma misdiagnosed as liposarcoma: a case report. Radiol Case Rep. 2021;16(2):364–8.CrossRefPubMed Cho J, Kinsey D, Kimchi ET, O’Carroll KS, Nguyen V, Alsabbagh M, et al. Retroperitoneal extra-adrenal myelolipoma misdiagnosed as liposarcoma: a case report. Radiol Case Rep. 2021;16(2):364–8.CrossRefPubMed
10.
Zurück zum Zitat Vaziri M, Sadeghipour A, Pazooki A, Shoolami LZ. Primary mediastinal myelolipoma. Ann Thorac Surg. 2008;85(5):1805–6.CrossRefPubMed Vaziri M, Sadeghipour A, Pazooki A, Shoolami LZ. Primary mediastinal myelolipoma. Ann Thorac Surg. 2008;85(5):1805–6.CrossRefPubMed
11.
Zurück zum Zitat Cina SJ, Gordon BM, Curry NS. Ectopic adrenal myelolipoma presenting as a splenic mass. Arch Pathol Lab Med. 1995;119(6):561–3.PubMed Cina SJ, Gordon BM, Curry NS. Ectopic adrenal myelolipoma presenting as a splenic mass. Arch Pathol Lab Med. 1995;119(6):561–3.PubMed
12.
Zurück zum Zitat Himuro N, Minakata T, Oshima Y, Tomita Y, Kataoka D, Yamamoto S, et al. Video-assisted thoracic surgery for primary myelolipoma of the posterior mediastinum. J Cardiothorac Surg. 2016;11(1):1.CrossRefPubMedPubMedCentral Himuro N, Minakata T, Oshima Y, Tomita Y, Kataoka D, Yamamoto S, et al. Video-assisted thoracic surgery for primary myelolipoma of the posterior mediastinum. J Cardiothorac Surg. 2016;11(1):1.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Zieker D, Königsrainer I, Miller S, Vogel U, Sotlar K, Steurer W, et al. Simultaneous adrenal and extra-adrenal myelolipoma – an uncommon incident: case report and review of the literature. World J Surg Oncol. 2008;6(1):72.CrossRefPubMedPubMedCentral Zieker D, Königsrainer I, Miller S, Vogel U, Sotlar K, Steurer W, et al. Simultaneous adrenal and extra-adrenal myelolipoma – an uncommon incident: case report and review of the literature. World J Surg Oncol. 2008;6(1):72.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Bokhari MR, Zulfiqar H, Garla VV. Adrenal myelolipoma. StatPearls [Internet]: StatPearls Publishing; 2022. Bokhari MR, Zulfiqar H, Garla VV. Adrenal myelolipoma. StatPearls [Internet]: StatPearls Publishing; 2022.
15.
Zurück zum Zitat Vigutto G, Lauro A, Vaccari S, Pirini MG, Diegoli M, D’Andrea V, et al. Giant retroperitoneal myelolipoma: an unusual diagnostic GI challenge-case report and review of the literature. Dig Dis Sci. 2019;64(12):3431–5.CrossRefPubMed Vigutto G, Lauro A, Vaccari S, Pirini MG, Diegoli M, D’Andrea V, et al. Giant retroperitoneal myelolipoma: an unusual diagnostic GI challenge-case report and review of the literature. Dig Dis Sci. 2019;64(12):3431–5.CrossRefPubMed
16.
Zurück zum Zitat Itani M, Wasnik AP, Platt JF. Radiologic–pathologic correlation in extra-adrenal myelolipoma. Abdom Imaging. 2014;39(2):394–7.CrossRefPubMed Itani M, Wasnik AP, Platt JF. Radiologic–pathologic correlation in extra-adrenal myelolipoma. Abdom Imaging. 2014;39(2):394–7.CrossRefPubMed
17.
Zurück zum Zitat Cyran KM, Kenney PJ, Memel DS, Yacoub I. Adrenal myelolipoma. AJR Am J Roentgenol. 1996;166(2):395–400.CrossRefPubMed Cyran KM, Kenney PJ, Memel DS, Yacoub I. Adrenal myelolipoma. AJR Am J Roentgenol. 1996;166(2):395–400.CrossRefPubMed
18.
Zurück zum Zitat Shaaban AM, Rezvani M, Tubay M, Elsayes KM, Woodward PJ, Menias CO. Fat-containing retroperitoneal lesions: imaging characteristics, localization, and Differential diagnosis. Radiographics: a review publication of the Radiological Society of North America Inc. 2016;36(3):710–34.CrossRefPubMed Shaaban AM, Rezvani M, Tubay M, Elsayes KM, Woodward PJ, Menias CO. Fat-containing retroperitoneal lesions: imaging characteristics, localization, and Differential diagnosis. Radiographics: a review publication of the Radiological Society of North America Inc. 2016;36(3):710–34.CrossRefPubMed
19.
Zurück zum Zitat Wang R, Fan Q, Tian R. 18F-FDG PET/CT imaging of adrenal liposarcoma. Clin Nucl Med. 2020;45(7):570–1.CrossRefPubMed Wang R, Fan Q, Tian R. 18F-FDG PET/CT imaging of adrenal liposarcoma. Clin Nucl Med. 2020;45(7):570–1.CrossRefPubMed
20.
Zurück zum Zitat Lam AK. Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocrine-related Cancer. 2017;24(3):R65–r79.CrossRefPubMed Lam AK. Lipomatous tumours in adrenal gland: WHO updates and clinical implications. Endocrine-related Cancer. 2017;24(3):R65–r79.CrossRefPubMed
21.
Zurück zum Zitat Neuhaus S, Barry P, Clark M, Hayes A, Fisher C, Thomas J. Surgical management of primary and recurrent retroperitoneal liposarcoma. J Br Surg. 2005;92(2):246–52.CrossRef Neuhaus S, Barry P, Clark M, Hayes A, Fisher C, Thomas J. Surgical management of primary and recurrent retroperitoneal liposarcoma. J Br Surg. 2005;92(2):246–52.CrossRef
Metadaten
Titel
Simultaneous adrenal and retroperitoneal myelolipoma resected by laparoscopic surgery: a challenging case
verfasst von
Hooman Kamran
Abdolreza Haghpanah
Mohammad Hossein Dabbaghmanesh
Lorenzo Defidio
Maryam Bazrafkan
Anahita Dehghani
Mehdi Shirazi
Nima Naderi
Amirreza Dehghanian
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Urology / Ausgabe 1/2023
Elektronische ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-023-01288-5

Weitere Artikel der Ausgabe 1/2023

BMC Urology 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.